Breaking News
Subscribe Now 0
Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 place See list
Close

COSCIENS Biopharma Inc (CSCI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.100 -0.050    -0.97%
11/10 - Closed. Currency in CAD ( Disclaimer )
  • Volume: 286
  • Bid/Ask: 5.080 / 5.200
  • Day's Range: 5.100 - 5.100
Type:  Equity
Market:  Canada
COSCIENS Biopharma 5.100 -0.050 -0.97%

CSCI User Rankings

 
Bellow, users are ranked according to the performance of their sentiments for the COSCIENS Biopharma Inc stock.
RankUsernameTotalClosedWinningWin %Chg. %
1Hermann Albrecht333100+72.41%
2Hermann Albrecht55480+63.11%
3gurmeet grewal222100+28.27%
4Maor Shoham111100+24.49%
5Yagnesh Porecha111100+20.16%
6davide garulli111100+13.36%
7Marcel Mitzscherling111100+2.96%
8thierry beaumier1100-9.43%
9Julien Massé1100-12.7%
10Ali Khan1100-15.48%
11Zak Khattabi1100-15.85%
12don bruce1100-21.37%
13Gabriel Monette1100-72.65%
14Bubbsy Brown1100-72.88%
15Gregory Lehr1100-75.15%
16cody fortin2200-143.33%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CSCI Comments

Write your thoughts about COSCIENS Biopharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mathieu Fournier
Mathieu Fournier Mar 09, 2021 10:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will this go back up?
Ali Ebrahimi
Ali Ebrahimi Feb 23, 2021 9:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why?!
mike croix
mike croix Feb 10, 2021 18:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bloomberg business announced today "WHO has recommended the Oxford AEterna Zentaris vaccine for adults over 18"
Dheeraj Kumar
Dheeraj Kumar Feb 10, 2021 18:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should we hold or short
mike croix
mike croix Feb 10, 2021 18:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why short?
Clrs Qwerty
Clrs Qwerty Feb 10, 2021 11:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy the dippp
Hassan Mahmood
Hassan Mahmood Feb 10, 2021 11:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it still a good buy?
Jeremy Scott
Jeremy Scott Feb 08, 2021 15:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Probably back up to eighth within a week
Amar Raj
Amar Raj Feb 08, 2021 15:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sounds good
Amar Raj
Amar Raj Feb 08, 2021 15:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anyone knows how up it will go
richard paquin
richard paquin Feb 08, 2021 15:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes we have a crystal ball
Jeremy Scott
Jeremy Scott Feb 08, 2021 15:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Here we go zhold tight
Jeremy Scott
Jeremy Scott Feb 08, 2021 11:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good things are coming soon
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email